Cellular Signaling: Signal → Receptor → Transduction → Response

1. Signal. An information-carrying molecule arrives at the cell — a peptide hormone, a growth factor, a small molecule. The signal itself does nothing chemical to the cell; its entire job is to be recognized.

2. Reception. A receptor protein binds the signal with specificity — shape and chemistry complementarity — and changes conformation. Recognition, not the ligand, is what crosses the membrane.

3. Transduction. The receptor's change is converted into intracellular chemistry: switch proteins flip, second messengers surge, kinases phosphorylate other proteins in cascades. This stage carries, amplifies, branches, and times the message.

4. Response. The cascade's endpoints do the visible work — metabolic enzymes switch state, transcription factors enter the nucleus, actin assembles, secretion fires. What an assay measures is some slice of this stage or the one before it.

GPCRs are the largest receptor family, but a research catalog crosses several listening architectures — and each dictates its own assay vocabulary:

G-protein-coupled receptors. Seven-transmembrane shape-change machines signaling through G proteins into cAMP and calcium — the incretin, GHRH, ghrelin, and melanocortin receptors, covered fully in the GPCR article. Readouts: cAMP accumulation, calcium flux, β-arrestin recruitment.

Receptor tyrosine kinases (RTKs). A different design entirely: single-pass receptors whose intracellular half is an enzyme. Ligand binding brings two receptor molecules together (dimerization); each phosphorylates the other's tyrosines (autophosphorylation); and the phosphotyrosines become docking sites that launch cascades — the MAPK pathway toward proliferation programs, the PI3K/Akt pathway toward growth and survival programs (Lemmon MA, Schlessinger J. Cell. 2010;141(7):1117–1134). This is the architecture of the insulin/IGF receptor family — the receptor world of IGF-1 LR3 — and of the VEGF receptors whose expression the BPC-157 literature examines. Readouts: receptor and substrate phosphorylation, typically by immunoblot or phospho-specific assays — a completely different bench vocabulary from GPCR work.

Ligand-gated ion channels. Receptors that are themselves pores: binding opens the channel, ions flow, and the membrane's electrical state changes in milliseconds — the fastest signaling class, dominant in neurotransmission.

Intracellular receptors. For signals that cross the membrane on their own (steroids, thyroid hormone): the receptor waits inside the cell and, once bound, often acts directly as a transcription factor. Peptides — charged, membrane-impermeant — do not use this route, which is precisely why peptide receptors sit on the surface.

One more listening route deserves its line because a catalog compound made it famous in the literature: transporters as uptake machinery. The tripeptide KPV is a characterized substrate of the intestinal peptide transporter PepT1 — carried into epithelial cells rather than signaling at a surface receptor — a reminder that recognition proteins other than receptors also shape what a peptide does in a model system.

Specificity comes from expression, not just binding. A ligand's selectivity sets which receptors it can activate; a cell's receptor expression sets which signals it can hear. The same peptide does different things in different cell types because the downstream wiring differs — the reason recombinant single-receptor cell lines are the workhorse of characterization: they make the response attributable.

Amplification is built in. Each stage turns one event into many — one receptor, many G proteins; one kinase, many substrates — which is how the sub-nanomolar EC50s of the receptor literature translate into full responses, and why tiny quantities of an unintended active species can matter, a point taken up below.

Pathways integrate and cross-talk. Cascades share components and modulate each other; a cell's response reflects the sum of its inputs. Combination designs — the logic of the catalog's fixed-ratio blends — exist to probe exactly this: two inputs, one integrating cell.

Every signal is built to end. G proteins hydrolyze their own GTP; phosphatases erase what kinases write; second messengers are degraded in seconds; receptors are desensitized and internalized after activation. Termination is not failure but design — signaling is information, and information requires the ability to say nothing (Hunter T. Cell. 2000;100(1):113–127). Experimentally, this is why timing matters: a readout taken at 5 minutes and at 5 hours can capture different phases of the same event, including the adaptation that follows sustained stimulation.

Choosing readouts is choosing which stage of which architecture to observe: cAMP or calcium for GPCR arms, phosphorylation for RTK arms, migration or transcription for the response stage — and multi-mechanism designs need one readout per arm to be interpretable, the recurring lesson of this library's comparison articles.

And underneath every readout sits the material question. Signaling assays run at concentrations where amplification makes small contamination visible: an impurity with receptor activity of its own — a deletion sequence, an oxidized variant — injects signal the experiment will attribute to the named compound. Interpretable signaling work starts with verified identity and purity; Certificates of Analysis are published on product pages as testing is completed.